YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
IGL-200 Successfully Approved by Health Canada
May 15th, 2023 – Era Biology’s Fully Automatic Kinetic Tube Reader (IGL-200), along with its adaptation reagents Fungus (1-3)-β-D-Glucan Detection Kit...
Meeting Era Biology at AACC 2023
The AACC congress, the American Association for Clinical Chemistry, is the premier global gathering for laboratory medicine professionals. This year, it will take p...
Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...